Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

Fri, 24th Jan 2014 10:58

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday.

-------

FTSE 100 - WINNERS

Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide general maintenance services on Lukoil's West Qurna-2 oilfield in southern Iraq.

-------

FTSE 250 - WINNERS

Close Brothers Group, up 1.7%. The financial services company said it is expecting a strong result for the first-half of its financial year, as the recovering economy boosted all three of its divisions. Close Brothers said its positive first-quarter performance has so far carried on into the second quarter, adding that it is confident in its outlook for the full financial year.

-------

FTSE 250 - LOSERS

Cairn Energy, down 4.2%. The oil and gas exploration company said it has been contacted by the Income Tax Department of India to discuss previous income tax assessments. It said the discussions cover tax assessments from the year ending March 31, 2007. While the discussions are taking place, the Income Tax Department has instructed Cairn to hold its shares in Cairn India Ltd.

-------

AIM - WINNERS

Victoria Oil & Gas, up 15%. The oil and gas exploration and development company said it has signed a settlement agreement with RSM Production Corp in relation to its cash-call dispute for the Logbaba gas project in Cameroon. Victoria said that the parties have agreed to an independent audit to determine the final balance payable by, or to be refunded to, RSM. The audit is due to start during the first quarter and be completed within 90 days.

ITM Power, up 12%. The energy storage and clean fuel company said it has secured a contract with AMEC and National Grid to assess efficient usage of Power-to-Gas energy storage. The project will look at the cost and energy benefit of deploying Power-to-Gas technology at specific sites on the UK gas network. Power-to-Gas is a technology which converts electrical power to a gas fuel.

Stadium Group, up 11%. The electronic technologies company said that it had traded in line with expectations in 2013. The company said that, as it had expected, it delivered "significantly improved" profits in the second half as it began to see benefits from its restructuring programme.

President Energy, up 7%. The company said the results of an independent audit of its prospective resources are substantially better than expectations. The company said its three drilling target prospect areas in Paraguay are now estimated to have a gross mean unrisked prospective resource of 1.09 billion barrels of oil equivalent, which equates to 647 million barrels of mean unrisked oil equivalent to President and 130 million barrels of mean risked resources. President Energy said earlier this month that the sites were expected to have a gross risked resource potential of in excess of 500 million barrels of oil equivalent.

Stellar Resources, up 6.7%. The company said Gold Mines of Wales (Operations) Ltd, in which Stellar owns 49.9%, agreed a 12-month extension of its exclusive option agreement with the Crown Estates.

-------

AIM - LOSERS

Strategic Minerals, off 28%. The company, which experienced a 94% increase in its share price in the week between January 15 and January 22, said it knows of no reason for its sharp drop in share price.

Akers Biosciences, down 15%. The company's shares have plummeted after it recommenced trading on the alternative market. The company also announced late on Thursday the pricing of its public offering on the NASDAQ. Akers will offer 2.7 million shares at USD5.50 each, hoping to raise around USD15 million in gross proceeds.

E-Therapeutics, down 18%. The firm has announced the temporary halt of recruitment into ETS2101 cancer trials because of a drug supply issue. Patients already receiving treatment will continue to be dosed in accordance with trial protocols.

Biome Technologies, down 11%. Biome said that it expects to meet forecasts for its full-year results. However, it noted that its Stanelco RF Technologies business had seen a subdued end to the year due to turbulence in the Chinese fibre optic market.

-------

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
23 Jan 2014 18:16

Akers Bioscience To Recommence Trading On AIM, Prices Offering

LONDON (Alliance News) - Akers Biosciences Inc said Thursday that its shares will recommence trading on AIM Friday, and announced the pricing of its public offering on the NASDAQ. Akers Biosciences will offer 2.7 million shares at USD5.50 each, hoping to raise around USD15 million in gross

Read more
18 Nov 2013 12:13

UK WINNERS & LOSERS: Aberdeen And Lloyds Jump On Scottish Widows Investment Partnership Deal

Read more
18 Nov 2013 11:02

Akers Biosciences To Convert Preferred Shares, Consolidate Shares Ahead Of NASDAQ Listing

Read more
15 Nov 2013 14:55

Akers Narrows Nine Month Pretax Losses As Revenues Rise

Read more
19 Jul 2013 07:28

Akers Biosciences revenue ahead of expectations

Akers Biosciences said first-half revenue was ahead of its own expectations after it capitalised on demand for its disposable breath alcohol detectors. In a trading update, Akers said it had delivered 4.9m of the detectors to its global partner, Chubeworkx. The Chube-branded detectors are certifi

Read more
10 Apr 2013 12:30

STOCKS NEWS EUROPE-UK small caps up 0.1 pct, lag blue chips

UK small caps are up 0.1 percent in afternoon trade, underperforming rises of 0.8 percent on both the mid-caps and the blue chips. Shares in Akers Biosciences jump 22 percent to 1.45 pence after the maker of rapid diagnostic screening and testing products says it expects full-year sales to

Read more
19 Feb 2013 12:02

STOCKS NEWS EUROPE-UK small caps up 0.1 percent at midday

The FTSE Small Cap index is 0.1 percent higher in midday trade, trailing blue chips, up 0.4 percent, and midcaps, which rise 0.7 percent. Akers Biosciences, a designer and manufacturer of rapid diagnostic screening and testing products, jumps 11 percent as it says sales of its test for hepa

Read more
19 Feb 2013 11:27

Akers Biosciences gets boost from new French regulation

Akers Biosciences was rewarded with a 11.3 per cent jump in its share price as the company announced a new product launch into the French market. The launch of disposable breath alcohol analysis tools is timely, as it coincides with a new French law coming into effect as of July 2012 citing that e

Read more
17 Sep 2012 07:34

Small caps: Iofina, WYG, Akers Biosciences

WYG, a management and technical consultancy to the built and natural environment, says it will report a small operating profit in the first six months of the current year. The group is also poised to buy all three of WYG Ireland's subsidiaries in Northern Ireland, securing the jobs of around 90 empl

Read more
6 Jan 2012 17:17

London close: Footsie finishes below best levels

London closed comfortably below its best levels of the day despite better than expected US jobless data which had some market commentators crying 'foul'. US non-farm payrolls grew by 200,000 during the month of December. The consensus estimate was for a reading of 155,000. Morgan Stanley has sugges

Read more
6 Jan 2012 09:31

Akers' profit expectations down the tubes

Diagnostic screening and testing products developer Akers Biosciences slumped to a 52-week low after warning that 2011 revenues will not come up to scratch. Largely as a result of issues with an order for Revelar Breath Tubes from Pulse Health, revenues for 2011 will be significantly below expectat

Read more
11 Apr 2011 16:00

Akers narrows losses after sales surge in 2010

Shares in screening and testing products group Akers Biosciences surged after the company reported a 72% increase in revenue after a "momentum-building" year. Revenue for the 12 months ended 31 December grew to $3.1m, from $1.8m in 2009, as a result of strong sales of its HIT-testing product ('PIFA

Read more
14 Jan 2011 14:00

Small caps round-up: Superglass, Akers Biosciences, TT electronics...

Insulation products maker Superglass is experiencing solid trading with specialist distributors and builders' merchants, but, as anticipated, there has been a slow start to the newly extended carbon emissions reduction target (CERT) programme. The expectation is that the company's trading performa

Read more
21 Jun 2010 16:00

UK SMALLCAP ROUNDUP: Eckoh Sees Return To 1H 2011 Profit

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps ECKOH PLC (ECK.LN), a voice recognition specialist, expects to return to a profit in the first half of fiscal 2011 after posting a narrowed pretax loss f

Read more
21 Jun 2010 12:30

UK SMALLCAP ROUNDUP: Photo-Me Fined GBP500,000 By FSA

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps PHOTO-ME INTERNATIONAL PLC (PHTM.LN), a photo booth operator, was Monday fined GBP500,000 by the U.K. Financial Services Authority for failing to keep in

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.